Herbas VPB

Print
EN | LT
LT - Arilkarbamido junginiai derinyje su kitais citostatiniais arba citotoksiniais agentais, skirti žmonių piktybiniams navikams gydyti
EN - Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers

Legal status

Patent expired

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/44 (2006.01)
A61K 31/535 (2006.01)
A61K 31/65 (2006.01)
A61K 31/435 (2006.01)
A61K 31/505 (2006.01)
A61K 31/47 (2006.01)
A61P 35/00 (2006.01)
European patent
(11) Number of the document 2305255
(13) Kind of document T
(96) European patent application number 10183659.1
Date of filing the European patent application 2002-12-03
(97) Date of publication of the European application 2011-04-06
(45) Date of publication and mention of the grant of the patent 2012-08-22
(46) Date of publication of the claims translation 2012-11-26
Priority applications
(30) Number Date Country code
334609 P 2001-12-03 US
Inventors
(72)
Trail, Pamela, US
Vincent, Patrick, US
Zhai, Yifan, US
Carter, Christopher A., US
Gibson, Neil, US
Hibner, Barbara, US
Humphrey, Rachel W., US
Dumas, Jacques, US
Riedl, Bernd, DE
Khire, Uday, US
Lowinger, Thimothy B., US
Scott, William J., US
Smith, Roger A., US
Wood, Jill E., US
Monahan, Mary-Katherine, US
Natero, Reina, US
Renick, Joel, US
Sibley, Robert N., US
Grantee
(73) Bayer HealthCare LLC, 100 Bayer Boulevard, Whippany, New Jersey 07981, US
Attorney or representative
(74) Genė Ona SRUOGIENĖ, UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius, LT
Title
(54) Arilkarbamido junginiai derinyje su kitais citostatiniais arba citotoksiniais agentais, skirti žmonių piktybiniams navikams gydyti
  Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
Last renewal fee
Payment date Validity (years) Amount
2021-11-29 347.00 EUR